Back
BeiGene Vs. ASLAN Pharmaceuticals Industry Stock Comparison
Sell
27
BGNE
BeiGene
Last Price:
156.30
Seasonality Move:
7.7%
Sell
40
ASLN
ASLAN Pharmaceuticals
Last Price:
0.61
Seasonality Move:
8.89%
Sell
27
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $154.79. The Score for BGNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
ASLAN Pharmaceuticals (ASLN)
is a Sell
Is ASLAN Pharmaceuticals a Buy, Sell or Hold?
- The current ASLAN Pharmaceuticals [ASLN] share price is $0.63. The Score for ASLN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ASLN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BGNE Stock Price Chart
ASLN Stock Price Chart
What is ASLAN Pharmaceuticals's stock price today?
-
The ASLAN Pharmaceuticals share price today is $0.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASLN is experiencing slight buying pressure.
BGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 43.66 | Sell |
Chaikin Money Flow: | 14748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.18 - 171.38) | Sell |
Bollinger Bands (100): | (155.51 - 185.95) | Sell |
ASLN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 48.41 | Sell |
Chaikin Money Flow: | 37557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.46 - 0.9) | Sell |
Bollinger Bands (100): | (0.45 - 0.89) | Sell |
BGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 160.6 | Sell |
20-day SMA: | 163.35 | Sell |
50-day SMA: | 158.29 | Sell |
200-day SMA: | 181.01 | Sell |
8-day EMA: | 158.73 | Sell |
20-day EMA: | 161.13 | Sell |
50-day EMA: | 162.72 | Sell |
200-day EMA: | 180.19 | Sell |
ASLN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.68 | Sell |
20-day SMA: | 0.73 | Sell |
50-day SMA: | 0.62 | Buy |
200-day SMA: | 1.47 | Sell |
8-day EMA: | 0.67 | Sell |
20-day EMA: | 0.68 | Sell |
50-day EMA: | 0.67 | Sell |
200-day EMA: | 1.38 | Sell |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.91 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $4.91 per share.
ASLAN Pharmaceuticals Earnings Growth & ASLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.00 per share.
BeiGene Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ASLAN Pharmaceuticals Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |